These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 8124547)
1. Consensus statement for the management of focal dystonias. Williams A Br J Hosp Med; 1993 Dec 15-1994 Jan 18; 50(11):655-9. PubMed ID: 8124547 [TBL] [Abstract][Full Text] [Related]
2. [Treatment of movement disorders using botulinum toxin]. Burgunder JM Schweiz Med Wochenschr; 1992 Sep; 122(36):1311-6. PubMed ID: 1411387 [TBL] [Abstract][Full Text] [Related]
3. Five-year experience in the treatment of focal movement disorders with low-dose Dysport botulinum toxin. Van den Bergh P; Francart J; Mourin S; Kollmann P; Laterre EC Muscle Nerve; 1995 Jul; 18(7):720-9. PubMed ID: 7783762 [TBL] [Abstract][Full Text] [Related]
4. [Clinical symptoms, diagnosis and treatment of focal dystonias]. Klivényi P; Vécsei L Orv Hetil; 2001 Oct; 142(42):2293-7. PubMed ID: 11760645 [TBL] [Abstract][Full Text] [Related]
5. Adult-onset focal dystonias: presentation and treatment options. Esper GJ; Charles PD; Davis TL; Robertson D Tenn Med; 1997 Jan; 90(1):18-20. PubMed ID: 8997156 [TBL] [Abstract][Full Text] [Related]
6. [Treatment of writer's cramp with botulinum toxin]. Amthor KF; Skjelland M; Heier MS Tidsskr Nor Laegeforen; 1994 Jun; 114(16):1830-1. PubMed ID: 8079300 [TBL] [Abstract][Full Text] [Related]
7. Botulinum toxin for neurological disorders in a movement disorders clinic in Singapore. Tan AK Singapore Med J; 1998 Sep; 39(9):403-5. PubMed ID: 9885719 [TBL] [Abstract][Full Text] [Related]
8. Local treatment of dystonia and spasticity with injections of botulinum-A toxin. Calne S Axone; 1993 Jun; 14(4):85-8. PubMed ID: 8274387 [TBL] [Abstract][Full Text] [Related]
9. Botulinum toxin in the treatment of dystonias--a hospital based study. Gupta M; Singh G; Khwaja G J Assoc Physicians India; 2003 May; 51():447-53. PubMed ID: 12974424 [TBL] [Abstract][Full Text] [Related]
10. Botulinum toxin treatment in patients with focal dystonia and hemifacial spasm. A multicenter study of the Italian Movement Disorder Group. Berardelli A; Formica A; Mercuri B; Abbruzzese G; Agnoli A; Agostino R; Caraceni T; Carella F; De Fazio G; De Grandis D Ital J Neurol Sci; 1993 Jun; 14(5):361-7. PubMed ID: 8354632 [TBL] [Abstract][Full Text] [Related]
12. Treatment of various movement disorders with botulinum A toxin injection: an experience of 900 patients. Poungvarin N; Devahastin V; Viriyavejakul A J Med Assoc Thai; 1995 Jun; 78(6):281-8. PubMed ID: 7561552 [TBL] [Abstract][Full Text] [Related]
13. Botulinum toxin treatment of occupational and focal hand dystonia. Karp BI Mov Disord; 2004 Mar; 19 Suppl 8():S116-9. PubMed ID: 15027063 [TBL] [Abstract][Full Text] [Related]
14. [Treatment of writer's cramp and other forms of limb dystonias with botulinum toxin]. Bogucki A Neurol Neurochir Pol; 1998; 32 Suppl 1():45-50. PubMed ID: 9608552 [TBL] [Abstract][Full Text] [Related]
15. Botulinum toxin in the treatment of neurological disorders. Denislic M; Pirtosek Z; Vodusek DB; Zidar J; Meh D Ann N Y Acad Sci; 1994 Mar; 710():76-87. PubMed ID: 8154763 [TBL] [Abstract][Full Text] [Related]
16. [Neurosurgical management of dystonias]. Taira T Rinsho Shinkeigaku; 2006 Nov; 46(11):970-1. PubMed ID: 17432236 [TBL] [Abstract][Full Text] [Related]
17. Focal dystonia, with special reference to writer's cramp. Gordon NS Int J Clin Pract; 2005 Sep; 59(9):1088-90. PubMed ID: 16115186 [TBL] [Abstract][Full Text] [Related]
18. Botulinum toxin in movement disorders. Papapetropoulos S; Singer C Semin Neurol; 2007 Apr; 27(2):183-94. PubMed ID: 17390263 [TBL] [Abstract][Full Text] [Related]
19. [Treatment of focal dystonia with botulinic toxin]. Gracia F; Castillo LC Rev Med Panama; 1996 Sep; 21(3):121-31. PubMed ID: 9280925 [TBL] [Abstract][Full Text] [Related]
20. [Botulinum toxin in blepharospasm, in hemifacial spasm, and in cervical dystonia: results in 33 patients]. Novis SA; De Mattos JP; De Rosso AL Arq Neuropsiquiatr; 1995 Sep; 53(3-A):403-10. PubMed ID: 8540813 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]